首页> 外文期刊>European Heart Journal: The Journal of the European Society of Cardiology >Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial (vol 39, pg 4112, 2018)

【24h】

Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial (vol 39, pg 4112, 2018)

机译：病变复杂性对皮脑癌症干预后有效静脉内血小板腺苷受体抑制的影响：核心凤凰患者核心实验室分析（Vol 39，PG 4112,2018）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Heart Journal: The Journal of the European Society of Cardiology》 |2019年第15期|共1页
作者
Stone Gregg W.; Genereux Philippe; Harrington Robert A.; White Harvey D.; Gibson C. Michael; Steg P. Gabriel; Hamm Christian W.; Mahaffey Kenneth W.; Price Matthew J.; Prats Jayne; Deliargyris Efthymios N.; Bhatt Deepak L.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词

相似文献

外文文献
中文文献

1. Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial (vol 39, pg 4112, 2018) [J] . Stone Gregg W., Genereux Philippe, Harrington Robert A., European Heart Journal: The Journal of the European Society of Cardiology . 2019,第15期

机译：病变复杂性对皮脑癌症干预后有效静脉内血小板腺苷受体抑制的影响：核心凤凰患者核心实验室分析（Vol 39，PG 4112,2018）
2. Coronary lesion complexity and the benefit of potent platelet inhibition after percutaneous coronary intervention [J] . Mukherjee Debabrata European Heart Journal: The Journal of the European Society of Cardiology . 2018,第46期

机译：经皮冠状动脉介入后有效血小板抑制的冠状动脉病变复杂性
3. Incidence, Predictors, and Outcomes of Acquired Thrombocytopenia After Percutaneous Coronary Intervention: A Pooled, Patient-Level Analysis of the CHAMPION Trials (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition) (vol 11, e005635, 2018) [J] . Groves E. M., Bhatt D. L., Steg P. G., Circulation. Cardiovascular interventions . 2018,第9期

机译：经皮冠状动脉干预后获得的血小板减少症的发病率，预测因子和结果：冠军试验的合并，患者水平分析（植物与标准治疗，实现血小板抑制的最佳管理）（第11卷，E005635,2018）
4. Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial [O] . Gregg W Stone, Philippe Généreux, Robert A Harrington, -1

机译：病变复杂性对围手术期不良事件的影响以及经皮冠状动脉介入治疗后有效抑制静脉血小板血小板二磷酸腺苷受体的益处：CHAMPION PHOENIX试验的10854名患者的核心实验室分析
5. Corrigendum to: Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial [O] . 2019

机译：勘犯：损伤复杂性对Peri-properation的影响以及有效的静脉内血小板腺苷腺苷受体抑制在经皮冠状动脉介入后的益处：来自冠军凤凰审判的10例854名患者的核心实验室分析

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号